Soon, the Centers for Medicare and Medicaid Services will begin the price negotiation process on a new set of 15 drugs. The new Trump administration should seize the opportunity to change the program ...
Health Affairs' Jeff Byers welcomes Rachel Sachs from Washington University in St. Louis and Deputy Editor Chris Fleming back ...
Teva Pharmaceuticals is suing the Centers for Medicare & Medicaid Services (CMS) for its implementation of the drug price negotiation program under the Inflation Reduction Act (IRA). Teva claims the ...
Novo Nordisk’s blockbuster GLP-1 medications Ozempic and Wegovy are among the next 15 drugs being targeted by the federal government for price setting negotiations. In a Jan. 17 press release, the U.S ...
Popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug manufacturers, the Biden ...
Spring has nearly sprung, and round two of the Inflation Reduction Act's (IRA's) negotiation period has begun. Each of the drugmakers that make the fifteen medicines selected for 2027 price cuts have ...
A provision of the summer’s One Big Beautiful Bill Act bumping a slew of orphan drugs from Medicare price negotiation is estimated to cost the program $8.8 billion over the course of a decade, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback